India wanted red flags on chip packets and soda. Big Food fought backIndia’s food regulator has dropped plans for colour-coded front-of-pack nutrition warnings after industry opposition, opting instead for si...
25 Aug, 2026, 03.45 PM IST
H1N1 cases are rising but no sign of new or more dangerous strain; experts urge caution, not panicH1N1 influenza cases are rising in Delhi and North India currently. Experts advise precautions for high-risk individuals and children. Ther...
24 Aug, 2026, 08.29 PM IST
Widening waistline: India's big, fat obesity hotspots may not be just the biggest cities anymoreIndia sees a significant rise in overweight and obese populations recently. Rural areas show a particularly sharp increase in these health ...
19 Aug, 2026, 01.18 PM IST
Lord’s Mark Industries announces license for biomescan analytics platformLord's Mark Industries has obtained a license for its groundbreaking Biomescan Analytics Platform, which specializes in assessing the gut m...
19 Aug, 2026, 11.50 AM IST
Parliamentary panel recommends mandatory kidney tests for all aged 20 yrs and above every 6 monthsA parliamentary committee proposes mandatory kidney function tests for adults aged twenty and above. High-risk individuals will undergo ann...
11 Aug, 2026, 08.32 PM IST
Eli Lilly’s Foundayo becomes first oral weight-loss drug approved in UK for diabetesBritain's regulator approved Eli Lilly's Foundayo pill for weight and diabetes. This treatment is not yet available through the NHS in the ...
11 Aug, 2026, 07.47 AM IST
School Assembly News Headlines, August 6, 2026: Top national, international, business, sports updates and thought of the daySchool Assembly News Headlines: The Lok Sabha in India has successfully passed a significant bill aimed at modernizing banking evidence law...
05 Aug, 2026, 05.27 PM IST
Losing weight fast on GLP-1 drugs? Your hair could be the next thing to goDermatologists report increased hair loss among GLP-1 drug users experiencing rapid weight reduction. This side effect, often telogen efflu...
02 Aug, 2026, 12.46 PM IST
GLP-1 demand stirs up hunger for obesity care talentDemand for nutrition professionals is rapidly rising across India. Hospitals and digital health platforms are hiring more dietitians and ed...
02 Aug, 2026, 06.07 AM IST
US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipelineIndian pharmaceutical firms experienced a challenging June quarter, marked by declining US business profits. Dr Reddy's and Cipla saw signi...
27 Jul, 2026, 06.44 AM IST
Monk fruit vs sugar: India's new sugar substitute is gaining popularity, but doctors say real problem isn't sugar, it's the way we eatMonk fruit is emerging as a popular natural sweetener in India's health food market, driven by growing consumer demand for zero-calorie and...
25 Jul, 2026, 10.37 PM IST
Make junk food costlier, tighten school canteen rules: Five steps ICMR suggests to curb childhood obesityIndia faces a significant childhood obesity crisis with 41 million affected children. New government policies aim to curb unhealthy food ma...
24 Jul, 2026, 01.21 PM IST
Cipla expects sequential recovery in North America on new product launches despite tariff uncertaintyCipla reported a 39% drop in net profit to ₹789 crore for the June quarter due to weakness in its North America business and margin compres...
23 Jul, 2026, 10.27 PM IST
Cipla in no hurry to launch semaglutide as Yurpeak gains tractionCipla is focusing on its tirzepatide brand Yurpeak in India's obesity market. Yurpeak has become the second largest GLP-1 product since its...
23 Jul, 2026, 10.24 PM IST
Dr Reddy’s aims to resume semaglutide supply by November after API fixDr Reddy's expects to resume semaglutide supplies by November after resolving quality issues. The company identified the root cause and pla...
23 Jul, 2026, 10.00 AM IST
Takeda Biopharmaceuticals gets DCGI nod for dengue vaccine QDENGATakeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individua...
20 Jul, 2026, 11.21 AM IST
Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killerIndia's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disea...
17 Jul, 2026, 02.18 PM IST